JON STEVENS: Open Payments
NPI 1780758367 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,704 in 89 payments from 21 companies in 2025. Trend: 2023 $340 · 2024 $520 · 2025 $1,704
Food & beverage: $1,704
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 8 | $302 |
| Amgen Inc. | 21 | $226 |
| Novartis Pharmaceuticals Corporation | 14 | $218 |
| Novo Nordisk Inc | 5 | $178 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $142 |
| AstraZeneca Pharmaceuticals LP | 6 | $109 |
| Merck Sharp & Dohme LLC | 4 | $96 |
| Kestra Medical Technology Services, Inc. | 4 | $96 |
| Edwards Lifesciences Corporation | 2 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $49 |
Products named: CAMZYOS, REPATHA, LEQVIO, Wegovy, JARDIANCE, VERQUVO, Assure WCD, FARXIGA.
Industry payments across AZ — which companies pay providers there.
